10-Q Filing

NEUROCRINE BIOSCIENCES INC CIK: 914475 Q1 2018

Filing Information

Form Type	10-Q
Accession Number	`0001564590-18-009860`
Period End Date	20180331
Filing Date	20180430
Fiscal Year	2018
Fiscal Period	Q1
XBRL Instance	nbix-20180331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 34 Cash Flow Statement 52

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$254.71M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$175.31M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$285.17M	USD	Point-in-time
Short-term investments, available for sale	`AvailableForSaleSecuritiesCurrent`	$261.22M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$31.13M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$44.62M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	220.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$7.86M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$8.61M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	88.79M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$513.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	89.88M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$554.92M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	88.79M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$10.81M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	89.88M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.82M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$247.36M	USD	Point-in-time
Long-term investments, available for sale	`AvailableForSaleSecuritiesNoncurrent`	$276.32M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.50M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$4.50M	USD	Point-in-time
Total assets	`Assets`	$817.59M	USD	Point-in-time
Total assets	`Assets`	$806.36M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$53.52M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$45.65M	USD	Point-in-time
Current portion of cease-use liability	`CeaseUseLiabilityCurrent`	$62.00K	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$731.00K	USD	Point-in-time
Current portion of deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateCurrent`	$731.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$113.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$85.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$54.43M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$46.47M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$8.04M	USD	Point-in-time
Deferred gain on sale of real estate	`DeferredGainOnSaleOfRealEstateNoncurrent`	$7.86M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred revenue	`DeferredRevenueNoncurrent`	$10.23M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.13M	USD	Point-in-time
Deferred rent	`DeferredRentCreditNoncurrent`	$3.11M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$369.62M	USD	Point-in-time
Convertible senior notes	`ConvertibleDebtNoncurrent`	$374.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$441.87M	USD	Point-in-time
Total liabilities	`Liabilities`	$445.45M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 89,882,062 as of March 31, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$90.00K	USD	Point-in-time
Common stock, $0.001 par value; 220,000,000 shares authorized; issued and outstanding shares were 89,882,062 as of March 31, 2018 and 88,793,903 as of December 31, 2017	`CommonStockValue`	$89.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.61B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$1.57B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-3.70M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.20B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.24B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$372.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$364.49M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$817.59M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$806.36M	USD	Point-in-time

Income Statement 34 line items

Line Item	Tag	Value	Unit	Period
Product sales, net	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Product sales, net	`SalesRevenueGoodsNet`	$71.09M	USD	1 Quarter
Total revenues	`Revenues`	$71.09M	USD	1 Quarter
Total revenues	`Revenues`	-	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$950.00K	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$48.95M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$51.88M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$58.64M	USD	1 Quarter
Sales, general and administrative	`SellingGeneralAndAdministrativeExpense`	$28.05M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$79.93M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$108.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-37.45M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-79.93M	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$201.00K	USD	1 Quarter
Deferred gain on real estate	`DeferredGainOnSaleOfRealEstate`	$879.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$7.50M	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$727.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$2.93M	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$1.61M	USD	1 Quarter
Total other (expense) income	`NonoperatingIncomeExpense`	$-4.37M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.90	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87.28M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.53M	shares	1 Quarter
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Net unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$83.00K	USD	1 Quarter
Net unrealized (losses) gains on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.85M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.66M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-78.24M	USD	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-78.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-41.82M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$489.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$786.00K	USD	1 Quarter
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$201.00K	USD	1 Quarter
Gain on sale of assets, net	`GainsLossesOnSalesOfAssets`	$879.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$326.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	-	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$4.26M	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-114.00K	USD	1 Quarter
Deferred rent	`IncreaseDecreaseInDeferredLiabilities`	$-28.00K	USD	1 Quarter
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-269.00K	USD	1 Quarter
Amortization of premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-512.00K	USD	1 Quarter
Non-cash share-based compensation expense	`ShareBasedCompensation`	$8.98M	USD	1 Quarter
Non-cash share-based compensation expense	`ShareBasedCompensation`	$19.88M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$779.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$13.50M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	-	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$750.00K	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-7.87M	USD	1 Quarter
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-6.93M	USD	1 Quarter
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-62.00K	USD	1 Quarter
Cease-use liability	`IncreaseDecreaseInCeaseUseLiability`	$-66.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-28.00K	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	-	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-38.49M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-77.36M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$139.35M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$57.88M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$84.09M	USD	1 Quarter
Sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$116.08M	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$18.00K	USD	1 Quarter
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.80M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.36M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$56.85M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-57.05M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$16.14M	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.53M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$16.14M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.53M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-18.98M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-79.40M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.17M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.81M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$69.17M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.15M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$179.81M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$259.21M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.